Published 2 days ago • loading... • Updated 1 day ago

Bioinformatics Market to Reach $34.41 Billion by 2031, Fueled by AI Integration and Growth in Precision Medicine

The global Bioinformatics Market is projected to grow from USD 18.63 billion in 2026 to USD 34.41 billion by 2031, expanding at a CAGR of 13.1% during the forecast period.
Market growth stems from the integration of AI-based tools and Cloud-based platforms into workflows, alongside the increasing adoption of NGS technologies driving demand for advanced biological data solutions.
Pharma and Biotech companies accounted for the largest market share in 2025, while the Multi-Omics Integration Segment is expected to register the fastest growth during the forecast period.
North America continues to hold significant market share due to strong research infrastructure, while China, India, Japan, South Korea, and Singapore in the region are emerging as fastest-growing markets.
Leading players including Thermo Fisher Scientific Inc, Illumina, QIAGEN, Agilent Technologies, and Hoffmann-La Roche Ltd are expanding their bioinformatics platforms to address rising demand for advanced data analytics and precision healthcare.

Insights by Ground AI

65 Articles

How AI helps scientists design the next generation of medicines

Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than synthetic chemistry (which are often used to…

1 day ago·Cambridge, United States

Read Full Article